Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

PhRMA raises dues for drug companies

Drug companies will collectively pay an extra $100 million in annual membership dues to industry group Pharmaceutical Research and Manufacturers of America (PhRMA).

Benchmark ACA premiums up 25% for 2017

The average monthly premium for the second-lowest cost silver plan on the Healthcare.gov marketplace will go up by 25 percent for 2017, according to HHS, the largest year-over-year jump in prices since the marketplace opened.

Precision biomarkers may improve breast cancer treatment

Precision biomarkers have been shown to be an effective tool in cancer care, but most evidence comes from clinical trials rather than real patient experiences. Christopher Friese, PhD, RN, of the University of Michigan School of Nursing in Ann Arbor, and colleagues are testing how practicing physicians are using a 21-gene recurrence score (RS) biomarker test in breast cancer patients.

CMS star ratings criticized for ignoring socioeconomic factors

CMS’s star rating system is more about the affluence of patients than quality of care, argued Missouri Health Association CEO Herb Kuhn and Vice President of Research and Analytics Mat Reidhead.

Fewer physicians, pharmacies faced DEA investigations as opioid addictions grew

A Washington Post investigation said the Drug Enforcement Administration (DEA) dropped its aggressive efforts against pharmacies, physicians, distributors and manufacturers to curb opioid abuse, mostly thanks to pressure from drug companies.

Enhanced recovery programs inform patients while decreasing pain, length of stay

Preparing patients before surgical procedures with enhanced recovery after surgery (ERAS) programs boosts patient knowledge while reducing recuperation time and decreasing necessary drug intervention, according to the results shown at two different healthcare facilities.

Hospital, insurer, pharma lobbyists push back against public option

The calls for a government-run insurance option on the Affordable Care Act’s insurance exchanges are being met with resistance from groups that had supported the law.

California’s ‘surprise’ medical bill law targeted by lawsuit

A new California law on out-of-network billing may be blocked by a lawsuit from a controversial medical association.

Displaying 5553 - 5560 of 8605

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.